Evolent Health, Inc. [NYSE: EVH] shares went lower by -4.81% from its previous closing of $10.61, now trading at the price of $10.10, also adding -0.51 points. Is EVH stock a buy or should you stay away?
The stock had a rather active trading session with the latest closing, by far recording 1.97 million contracts. Compared to the average trading volume of EVH shares, the company saw a far better performance. Moreover, the stock has a 82.89M float and a +2.43% run over in the last seven days. EVH share price has been hovering between $19.13 and $5.50 lately, and is definitely worthy of attention.
Evolent Health, Inc. [NYSE:EVH]: Analyst Rating and Earnings
Its stock price has been found in the range of 5.50 to 19.13. This is compared to its latest closing price of $10.61.
Keep an eye out for the next scheduled publication date for this company’s financial results, which are expected to be released on Tue 25 Feb (In 41 Days).
Fundamental Analysis of Evolent Health, Inc. [EVH]
Now let’s turn to look at profitability: with a current Operating Margin for Evolent Health, Inc. [EVH] sitting at +3.78 and its Gross Margin at +40.62, this company’s Net Margin is now -15.00%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.
This company’s Return on Total Capital is 1.84, and its Return on Invested Capital has reached -3.50%. Its Return on Equity is -4.89, and its Return on Assets is -3.47. These metrics suggest that this Evolent Health, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.
Turning to investigate this organization’s capital structure, Evolent Health, Inc. [EVH] has generated a Total Debt to Total Equity ratio of 19.32. Similarly, its Total Debt to Total Capital is 16.20, while its Total Debt to Total Assets stands at 12.83. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 4.32, and its Long-Term Debt to Total Capital is 19.32.
What about valuation? This company’s Enterprise Value to EBITDA is 8.65 and its Total Debt to EBITDA Value is 3.24. The Enterprise Value to Sales for this firm is now 0.73, and its Total Debt to Enterprise Value stands at 0.15. Evolent Health, Inc. [EVH] has a Price to Book Ratio of 1.38.
Shifting the focus to workforce efficiency, Evolent Health, Inc. [EVH] earns $165,017 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 8.29 and its Total Asset Turnover is 0.41. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.81 and its Current Ratio is 1.81. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Evolent Health, Inc. [EVH] has 83.82M shares outstanding, amounting to a total market cap of $846.57M. Its stock price has been found in the range of 5.50 to 19.13. At its current price, it has moved down by -47.20% from its 52-week high, and it has moved up 83.64% from its 52-week low.
This stock’s Beta value is currently 1.12, which indicates that it is 6.36% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 59.94. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Evolent Health, Inc. [EVH] a Reliable Buy?
Shares of Evolent Health, Inc. [EVH], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.